Asthma and Allergic Diseases Cooperative Research Centers
Forecasted
This grant supports multi-center research centers advancing clinical and basic studies on asthma and allergic diseases, focusing on disease mechanisms, treatment, and immune pathways using human-based research.
Funder: National Institutes of Health
Due Dates (Anticipated): May 2027 (Full application deadline, projected)
Funding Amounts: $7,674,000 total program funding (anticipated); typical award ceiling not specified; project period expected to start March 2028
Summary: Supports multi-center, multidisciplinary, translational research in asthma and allergic diseases, including basic, clinical, and mechanistic studies.
Description
The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, anticipates continued support for the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC). This program is the cornerstone of NIAID’s clinical and basic research efforts in asthma, upper airway allergic/inflammatory diseases, food and drug allergies, atopic dermatitis, and related allergic diseases. The AADCRC aims to investigate mechanisms underlying onset, progression, treatment, and treatment response for these conditions.
The program is designed to foster multi-center, multidisciplinary, and translational research. Research directions may include:
- Mechanistic studies of disease onset and progression
- Evaluation of treatment modalities, including in small clinical trials or observational studies
- Projects focused on immune pathways, primarily using human materials
The AADCRC is the only NIAID program specifically promoting this breadth of collaborative research in asthma and allergic diseases.
